A Randomised Control Trial to Evaluate Efficacy and Safety of Two Different Protocols of Endometrial Priming for Embryo Transfer.
Phase 4
18 Years
50 Years
18 Years
50 Years
Open (Enrolling)
Female
Sterility
Female
Sterility
Trial Information
A Randomised Control Trial to Evaluate Efficacy and Safety of Two Different Protocols of Endometrial Priming for Embryo Transfer.
Inclusion Criteria:
- Women between 18-50 years old with desire of children and needs of embryo transfer.
- Plasma prolactin less than 30.
- Uterine cavity that allow pregnancy, body mass index between 20-30.
- And signed consent inform.
Exclusion Criteria:
- History of estrogen dependent cancer, unknown origin vaginal bleeding.
- Ovarian cyst.
- Contraindications to be pregnant.
- Estrogen allergy.
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Difference between day means in endometrial priming to achieve 7 mm.
Outcome Time Frame:
11-16 days
Safety Issue:
No
Authority:
Spain: Agencia Española de Medicamentos y Productos Sanitarios
Study ID:
UREP-PREPENDO-2010
NCT ID:
NCT01430650
Start Date:
July 2010
Completion Date:
December 2013
Related Keywords:
- Sterility
- Oral estrogens
- transdermal estrogens
- endometrial priming
- Adenoma
- Infertility
Name | Location |
|---|
